CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity

被引:52
作者
Bai, Ying [1 ,2 ,6 ]
Liu, Ruolan [1 ]
Huang, DeRen [3 ]
La Cava, Antonio [4 ]
Tang, Yi-yuan [2 ]
Iwakura, Yoichiro [5 ]
Campagnolo, Denise I. [1 ]
Vollmer, Timothy L. [1 ]
Ransohoff, Richard M. [3 ]
Shi, Fu-Dong [1 ,2 ]
机构
[1] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA
[2] Dalian Univ Technol, Inst Neuroinformat, Dalian, Peoples R China
[3] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA
[5] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan
[6] Dalian Univ Technol, Xin Hua Hosp, Div Neurol, Dalian, Peoples R China
关键词
autoantibodies; CCL2; myasthenia gravis; Th17;
D O I
10.1002/eji.200737973
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development and function of Th17 cells are influenced in part by the cytokines TGF-P, IL-23 and IL-6, but the mechanisms that govern recruitment and activity of Th17 cells during initiation of autoirnmunity remain poorly defined. We show here that the development of autoreactive Th17 cells in secondary lymphoid organs in experimental autoimmune myasthenia gravis - an animal model of human myasthenia gravis - is modulated by IL-6-producing CD11b(+) cells via the CC chemokine ligand 2 (CCL2). Notably, acetylcholine receptor (AChR)-reactive Th17 cells provide help for the B cells to produce anti-AChR antibodies, which are responsible for the impairment of the neuromuscular transmission that contributes to the clinical manifestations of autoirnmunity, as indicated by a lack of disease induction in IL-17-deficient mice. Thus, Th17 cells can promote humoral autoirnmunity via a novel mechanism that involves CCL2.
引用
收藏
页码:1877 / 1888
页数:12
相关论文
共 45 条
[1]   CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE [J].
Bailey, Samantha L. ;
Schreiner, Bettina ;
McMahon, Eileen J. ;
Miller, Stephen D. .
NATURE IMMUNOLOGY, 2007, 8 (02) :172-180
[2]   Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice [J].
Balasa, B ;
Deng, CS ;
Lee, J ;
Bradley, LM ;
Dalton, DK ;
Christadoss, P ;
Sarvetnick, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (03) :385-391
[3]   CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease [J].
Bennett, Jami L. ;
Elhofy, Adam ;
Charo, Israel ;
Miller, Stephen D. ;
Dal Canto, Mauro C. ;
Karpus, William J. .
VIRAL IMMUNOLOGY, 2007, 20 (01) :19-33
[4]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[5]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[6]  
CHRISTADOSS P, 1989, CRIT REV IMMUNOL, V9, P247
[7]   Myasthenia gravis: past, present, and future [J].
Conti-Fine, Bianca M. ;
Milani, Monica ;
Kaminski, Henry J. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (11) :2843-2854
[8]   Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/1pr lupus-prone mice [J].
de Lema, GP ;
Maier, H ;
Franz, TJ ;
Escribese, M ;
Chilla, S ;
Segerer, S ;
Camarasa, N ;
Schmid, H ;
Banas, B ;
Kalaydjiev, S ;
Busch, DH ;
Pfeffer, K ;
Mampaso, F ;
Schlöndorff, D ;
Luckow, B .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12) :3592-3601
[9]   Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production [J].
Deng, CS ;
Goluszko, E ;
Tüzün, E ;
Yang, H ;
Christadoss, P .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :1077-1083
[10]   Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration [J].
Flaishon, L ;
Becker-Herman, S ;
Hart, G ;
Levo, Y ;
Kuziel, WA ;
Shachar, I .
BLOOD, 2004, 104 (04) :933-941